Literature DB >> 26588264

A Newfound Cancer-Activating Mutation Reshapes the Energy Landscape of Estrogen-Binding Domain.

Wei Huang1, Krishnakumar M Ravikumar1, Sichun Yang1.   

Abstract

The ligand-binding domain (LBD) of an estrogen receptor undergoes a large conformational switching from an inactive to active state in response to hormone stimuli. Very recently, a novel D538G mutant has been identified to be active in advanced breast cancer tumors. Here, we ask if molecular simulations can provide insight on its mechanistic impact on the receptor's activation status. It has been challenging for ab initio modeling to identify two distinct conformations of a single amino acid sequence as large as that of the LBD. Using a coarse-grained (CG) model, we are able to correctly reproduce this LBD conformational switching. Furthermore, we found that the D538G mutation reshapes the energy landscape by stabilizing both active and inactive conformations, but preferring the active by 1.5 kcal/mol. This observation is consistent with the concept of a mutation-shifting landscape and provides a structural explanation for the oncogenic D538G mutation at the detailed conformational level.

Entities:  

Year:  2014        PMID: 26588264     DOI: 10.1021/ct500313e

Source DB:  PubMed          Journal:  J Chem Theory Comput        ISSN: 1549-9618            Impact factor:   6.006


  3 in total

1.  Theoretical modeling of multiprotein complexes by iSPOT: Integration of small-angle X-ray scattering, hydroxyl radical footprinting, and computational docking.

Authors:  Wei Huang; Krishnakumar M Ravikumar; Marc Parisien; Sichun Yang
Journal:  J Struct Biol       Date:  2016-08-02       Impact factor: 2.867

2.  An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position.

Authors:  Paulo C T Souza; Larissa C Textor; Denise C Melo; Alessandro S Nascimento; Munir S Skaf; Igor Polikarpov
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

3.  A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast Cancers.

Authors:  Matic Pavlin; Angelo Spinello; Marzia Pennati; Nadia Zaffaroni; Silvia Gobbi; Alessandra Bisi; Giorgio Colombo; Alessandra Magistrato
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.